Premium
P3‐015: ALLOPREGNANOLONE SHOWS SIGNIFICANT EFFECT ON THE LIPID PATHWAYS FROM PLASMA METABOLOMIC ANALYSIS OF ALZHEIMER'S CLINICAL TRIAL
Author(s) -
Shang Yuan,
Hernandez Gerson D.,
Lopez Claudia,
Yin Fei,
Schneider Lon S.,
Brinton Roberta Diaz
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.3041
Subject(s) - medicine , allopregnanolone , dementia , endocrinology , metabolomics , placebo , psychology , disease , bioinformatics , neuroactive steroid , biology , pathology , receptor , gabaa receptor , alternative medicine